BE vs UAL

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a missing Altman Z-Score prevents a full distress risk assessment. Despite explosive revenue growth of 57.1% and strong recent earnings surprises, the company trades at extreme valuations (P/E of 2069, P/B of 52.44) far above sector averages, while profitability remains thin (ROE: 2.93%, net margin: 0.84%). Aggressive insider selling worth $20.85M over the past six months and a bearish technical trend (10/100) further signal caution. Although analysts recommend a 'buy', the stock appears significantly overvalued relative to both defensive (Graham Number: $2.09) and growth-based intrinsic value ($0.49), suggesting elevated downside risk.

UAL presents a stable financial health profile with a Piotroski F-Score of 4/9 and is currently trading below its Graham Number of $104.13. While valuation metrics like the P/E ratio (9.70) and analyst targets ($130.17) suggest significant upside, the company faces liquidity pressures with a current ratio of 0.65. Strong ROE (23.99%) and a consistent track record of earnings beats provide a fundamental floor. However, bearish insider sentiment and a high PEG ratio indicate caution regarding immediate growth acceleration.